<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="http://feeds.feedburner.com/~d/styles/rss2full.xsl" type="text/xsl" media="screen"?><?xml-stylesheet href="http://feeds.feedburner.com/~d/styles/itemcontent.css" type="text/css" media="screen"?><rss xmlns:pheedo="http://www.pheedo.com/namespace/pheedo" version="2.0">
	<channel>
		<title>Chronic Myeloid Leukemia News</title>
		<link>http://news.cancerbasics.info/chronic_myeloid_leukemia_news.html</link>
		<description>Latest Chronic Myeloid Leukemia News updated hourly. Subscribe and stay informed on latest cancer news for chronic myeloid leukemia.</description>
		<language>en-us</language>
		<webMaster>cancerbasics.info@gmail.com</webMaster>
		<pubDate>Thu, 20 Nov 2008 00:44:12 +0100</pubDate>
		<lastBuildDate>Thu, 20 Nov 2008 00:44:12 +0100</lastBuildDate>
		<category>Health</category>
		<docs>http://blogs.law.harvard.edu/tech/rss</docs>
		<ttl>60</ttl>
		<image>
			<url>http://news.cancerbasics.info/images/feedfavicon.png</url>
			<title>Chronic Myeloid Leukemia News</title>
			<link>http://news.cancerbasics.info/chronic_myeloid_leukemia_news.html</link>
			<description>Latest Chronic Myeloid Leukemia News updated hourly. Subscribe and stay informed on latest cancer news for chronic myeloid leukemia.</description>
			<width>88</width>
			<height>88</height>
		</image>
		<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.feedburner.com/chronic-myeloid-leukemia-news" type="application/rss+xml" /><item>
			<title>Latest Chronic Myeloid Leukemia News</title>
			<link>http://news.cancerbasics.info/chronic_myeloid_leukemia_news.html</link>
			<description>Latest news for Chronic Myeloid Leukemia updated every 30 minutes, dedicated for patients, caregivers, physicians and researchers whose interest are chronic myeloid leukemia, chronic myelogenous leukemia, cml, leukemia, chronic.</description>
			<pubDate>Thu, 20 Nov 2008 00:44:12 +0100</pubDate>
		</item>
		<item>
			<title>Cancer Detection Lab Tests Online</title>
			<link>http://news.cancerbasics.info/cancernews/pmdcancer/61374</link>
			<description>Order cancer detection lab tests online safely and securely. Physicians Order Included. Always Secure. - Read more ...</description>
			<pubDate>Thu, 20 Nov 2008 00:44:12 +0100</pubDate>
		</item>
		<item>
			<title>Leukemia Ribbon</title>
			<link>http://news.cancerbasics.info/cancernews/ribbonleu/leukemia-awareness-ribbon-lapel-pin</link>
			<description>Leukemia Support Ribbon Lapel Pins. - Made in U.S.A. - Help Increase Leukemia Awareness and Early Detection.</description>
			<pubDate>Thu, 20 Nov 2008 00:44:12 +0100</pubDate>
		</item>
		<item>
			<title>Chronic Myeloid Leukemia: Diagnosis and Treatment</title>
			<description>Chronic myeloid leukemia  has become a model in research and management among malignant disorders. Since the discovery of the presence of a unique and constant chromosomal abnormality slightly more than 40 years ago, substantial progress has been made in the understanding of the biology of the ...&lt;br style="clear: both;"/&gt;
  &lt;img alt="" style="border: 0; height:1px; width:1px;" border="0" src="http://www.pheedo.com/img.phdo?i=3787f637cb6b0fa440e51526f289b8a5" height="1" width="1"/&gt;
&lt;img src="http://www.pheedo.com/feeds/tracker.php?i=3787f637cb6b0fa440e51526f289b8a5" style="display: none;" border="0" height="1" width="1" alt=""/&gt;</description>
		</item>
		<item>
			<title>Chronic Myeloid Leukemia: Current Application of Cytogenetics and Molecular Testing for Diagnosis and Treatment</title>
			<description>Chronic myeloid leukemia provides an illustrative disease model for both molecular pathogenesis of cancer and rational drug therapy. Chronic myeloid leukemia is a clonal stem cell disease caused by an acquired somatic mutation that fuses, through chromosomal translocation, the abl and bcr genes on ...&lt;br style="clear: both;"/&gt;
  &lt;img alt="" style="border: 0; height:1px; width:1px;" border="0" src="http://www.pheedo.com/img.phdo?i=39432807d09eedaa8efe174404b19a14" height="1" width="1"/&gt;
&lt;img src="http://www.pheedo.com/feeds/tracker.php?i=39432807d09eedaa8efe174404b19a14" style="display: none;" border="0" height="1" width="1" alt=""/&gt;</description>
		</item>
		<item>
			<title>Imatinib-induced nail hyperpigmentation in chronic myeloid leukemia</title>
			<description>Sir, Imatinib mesylate has revolutionized the treatment of chronic myeloid leukemia  and has been recently approved as first-line treatment. Most of the patients receiving imatinib experience hematological or non-hematological side effects. Skin changes are the most common non-hematological ...&lt;br style="clear: both;"/&gt;
      &lt;a href="http://www.pheedo.com/click.phdo?s=ae3db20916f347c2dab3c6c425d9c4e0"&gt;&lt;img alt="" style="border: 0;" border="0" src="http://www.pheedo.com/img.phdo?s=ae3db20916f347c2dab3c6c425d9c4e0"/&gt;&lt;/a&gt;
  &lt;img src="http://www.pheedo.com/feeds/tracker.php?i=ae3db20916f347c2dab3c6c425d9c4e0" style="display: none;" border="0" height="1" width="1" alt=""/&gt;</description>
		</item>
		<item>
			<title>Oral agent shows promise for chronic myeloid leukemia.</title>
			<description>SAN DIEGO - A new oral drug for patients with Gleevec-resistant chronic myeloid leukemia led to remission in 86% of patients in a phase I trial. Obviously we're excited by that, Charles L. Sawyers, M.D., said at a press briefing during the annual meeting of the American Society of Hematology. The ...&lt;br style="clear: both;"/&gt;
  &lt;img alt="" style="border: 0; height:1px; width:1px;" border="0" src="http://www.pheedo.com/img.phdo?i=556c20d2aef628b1b5a9ba510d92cacd" height="1" width="1"/&gt;
&lt;img src="http://www.pheedo.com/feeds/tracker.php?i=556c20d2aef628b1b5a9ba510d92cacd" style="display: none;" border="0" height="1" width="1" alt=""/&gt;</description>
		</item>
		<item>
			<title>The chronic leukemias of myeloid origin.</title>
			<description>Chronic leukemias of myeloid origin  disorders are the second major category of chronic leukemias. The first major category of chronic leukemias, leukemias of lymphoid origin, was discussed in part one of this two-part series . This group of neoplastic disorders ...&lt;br style="clear: both;"/&gt;
  &lt;img alt="" style="border: 0; height:1px; width:1px;" border="0" src="http://www.pheedo.com/img.phdo?i=b08afc00b3299e3086f24be5119894ad" height="1" width="1"/&gt;
&lt;img src="http://www.pheedo.com/feeds/tracker.php?i=b08afc00b3299e3086f24be5119894ad" style="display: none;" border="0" height="1" width="1" alt=""/&gt;</description>
		</item>
		<item>
			<title>Chronic Myeloid Leukemia - Gleevec resistance is opening a market for synergistic use.</title>
			<description>M2 PRESSWIRE-18 February 2003-Research and Markets: Chronic Myeloid Leukemia - Gleevec resistance is opening a market for synergistic use1994-2003 M2 COMMUNICATIONS LTD RDATE:02152003 With CML`s relatively low prevalence, the potential market for drugs launched for this indication historically ...&lt;br style="clear: both;"/&gt;
  &lt;img alt="" style="border: 0; height:1px; width:1px;" border="0" src="http://www.pheedo.com/img.phdo?i=6bc27cb7eb9c2eed72e531dc587ad633" height="1" width="1"/&gt;
&lt;img src="http://www.pheedo.com/feeds/tracker.php?i=6bc27cb7eb9c2eed72e531dc587ad633" style="display: none;" border="0" height="1" width="1" alt=""/&gt;</description>
		</item>
		<item>
			<title>Bone marrow morphological changes in patients of chronic myeloid leukemia treated with imatinib mesylate</title>
			<description>Introduction Chronic myeloid leukemia  is a clonal stem cell disorder associated with the reciprocal translocation between chromosomes 9 and 22 resulting in formation of the bcr-abl chimeric protein with tyrosine  kinase activity. [1] The enhanced tyrosine kinase activity has been ...&lt;br style="clear: both;"/&gt;
  &lt;img alt="" style="border: 0; height:1px; width:1px;" border="0" src="http://www.pheedo.com/img.phdo?i=1a84bbe449a20e6f6bc6abce1bbcf9c2" height="1" width="1"/&gt;
&lt;img src="http://www.pheedo.com/feeds/tracker.php?i=1a84bbe449a20e6f6bc6abce1bbcf9c2" style="display: none;" border="0" height="1" width="1" alt=""/&gt;</description>
		</item>
		<item>
			<title>Panel endorses dasatinib for imatinib-resistant CML.</title>
			<description>ATLANTA - Based on input from an expert advisory panel, the oral tyrosine kinase inhibitor dasatinib may be approved by the Food and Drug Administration for the treatment of imatinib-resistant or -intolerant adults with chronic myeloid leukemia. Other potential indications include treatment of ...&lt;br style="clear: both;"/&gt;
  &lt;img alt="" style="border: 0; height:1px; width:1px;" border="0" src="http://www.pheedo.com/img.phdo?i=0c0487e63e83c01e86254aee6754bc90" height="1" width="1"/&gt;
&lt;img src="http://www.pheedo.com/feeds/tracker.php?i=0c0487e63e83c01e86254aee6754bc90" style="display: none;" border="0" height="1" width="1" alt=""/&gt;</description>
		</item>
		<item>
			<title>New Studies Identify Advances in Treatment Of Chronic Myeloid Leukemia.</title>
			<description>ATLANTA, Dec. 10 /PRNewswire/ - Offering promise in the battle against cancer, the results from five studies highlighting new advances in the treatment of chronic myeloid leukemia  - a slow-progressing, malignant bone marrow cancer - will be presented at the 47th Annual Meeting of the ...&lt;br style="clear: both;"/&gt;
  &lt;img alt="" style="border: 0; height:1px; width:1px;" border="0" src="http://www.pheedo.com/img.phdo?i=979e62401865222c5f87800841b92665" height="1" width="1"/&gt;
&lt;img src="http://www.pheedo.com/feeds/tracker.php?i=979e62401865222c5f87800841b92665" style="display: none;" border="0" height="1" width="1" alt=""/&gt;</description>
		</item>
		<item>
			<title>Video and Photo: Tasigna Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Existing Therapies.</title>
			<description>- Tasigna produced responses in 40% of patients with Philadelphia chromosome-positive chronic myeloid leukemia resistant or intolerant to prior treatment - Approval and availability in US means Novartis can offer physicians and patients a comprehensive treatment approach for this disease EAST ...&lt;br style="clear: both;"/&gt;
      &lt;a href="http://www.pheedo.com/click.phdo?s=385d9edb9732633046dd55302d71be8a"&gt;&lt;img alt="" style="border: 0;" border="0" src="http://www.pheedo.com/img.phdo?s=385d9edb9732633046dd55302d71be8a"/&gt;&lt;/a&gt;
  &lt;img src="http://www.pheedo.com/feeds/tracker.php?i=385d9edb9732633046dd55302d71be8a" style="display: none;" border="0" height="1" width="1" alt=""/&gt;</description>
		</item>
		<item>
			<title>Cancer Supplements</title>
			<link>http://news.cancerbasics.info/cancernews/supplements/7210024</link>
			<description>Discount Natural Cancer Supplements and Products and natural vitamin supplements at 20% to 70% off retail. Read more ...</description>
			<pubDate>Thu, 20 Nov 2008 00:44:12 +0100</pubDate>
		</item>
	<feedburner:awareness xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0">http://api.feedburner.com/awareness/1.0/GetFeedData?uri=chronic-myeloid-leukemia-news</feedburner:awareness></channel>
</rss>
